Table 4.
Variable | Univariate analysis | Multivariate analysis* | ||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Age, yr | 1.081 (0.922–1.269) | .337 | ||
Male | 1.588 (0.144–17.561) | .706 | ||
Weight | 1.096 (0.991–1.212) | .073 | ||
Height | 1.158 (1.006–1.332) | .041 | 1.158 (1.006–1.332) | .041 |
Body mass index | 1.106 (0.820–1.493) | .508 | ||
Never smoker | Ref. | . | ||
Ever-smokers | N/E | N/E | ||
Pack-yr | 1.037 (0.993–1.083) | .098 | ||
GAP point | 2.313 (0.838–6.385) | .105 | ||
Antifibrotic agent | N/E | .N/E | ||
Duration of PFD | 1.001 (0.997–1.005) | .543 | ||
Dyspnea, mMRC | 1.717 (0.656–4.491) | .271 | ||
Pulmonary function test | ||||
FVC, % predicted | 0.987 (0.945–1.031) | .555 | ||
FEV1, % predicted | 0.990 (0.946–1.035) | .648 | ||
DLco, % predicted | 0.966 (0.904–1.032) | .308 | ||
Six-minute walk test | ||||
Distance (m) | 0.998 (0.992–1.004) | .421 | ||
Initial SpO2 (%) | 1.303 (0.843–2.015) | .233 | ||
Nadir SpO2 (%) | 1.034 (0.912–1.174) | .601 | ||
Arterial oxygen pressure | 0.997 (0.968–1.026) | .821 | ||
PaCO2 (mm Hg) | 0.973 (0.800–1.183) | .784 | ||
WBC | 0.774 (0.495–1.212) | .263 | ||
IL-6 | 0.888 (0.731–1.080) | .235 | ||
CRP | 0.203 (0.014–2.961) | .244 |
CI = confidence interval, CRP = C-reactive protein, DLco = diffusing capacity of the lungs for carbon monoxide, FEV1 = forced expiratory volume in one second, FVC = forced vital capacity, GAP = gender-age-pulmonary function, IL-6 = interleukin-6, LCQ = Leicester cough questionnaire, MCID = minimal clinically important differences, mMRC = modified medical research council, N/E = not estimable since none was observed in a certain subgroup, OR = odds ratio, PaCO2 = partial pressure of carbon dioxide, PFD = Pirfenidone, Ref = reference group, SpO2 = saturation of percutaneous oxygen, WBC = white blood cell.
In a multivariate logistic regression, the statistically significant variables were selected in a backward elimination method with 0.05 alpha level.